Outcomes From Unrelated Donor Hematopoietic Stem Cell Transplantation

Cancer Control - United States
doi 10.1177/107327481101800402
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Successful Treatment of Griscelli Syndrome With Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2002English

Alternative Donor Sources for Hematopoietic Stem Cell Transplantation

2013English

MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation

Science Translational Medicine
Medicine
2012English

HLA-DPA1 Mismatch Is Associated With Decreased Overall Survival Following Unrelated Donor Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Unrelated Donor Stem Cell Transplantation in Adult Patients With Thalassemia

Bone Marrow Transplantation
TransplantationHematology
2005English

KIR3DL1/S1 and HLA-B Alleles Combine to Influence Unrelated Hematopoietic Stem Cell Transplantation (HSCT) Outcomes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Availability of Unrelated Donors for Hematopoietic Stem Cell Transplantation for Hemoglobinopathies

Bone Marrow Transplantation
TransplantationHematology
2003English

HLA-Mismatch Is Associated With Worse Outcomes After Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy